Price Alert

RedHill Biopharma Ltd. (RDHL)

NASDAQ: RDHL · Real-Time Price · USD

1.37

-0.02 (-1.44%)

At close: Aug 15, 2025, 3:59 PM

1.39

1.36%

After-hours: Aug 15, 2025, 06:45 PM EDT

RedHill Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	4.62M	1.88M	7.28M	7.28M	5.57M	5.57M	7M	17.57M	19.97M	15.2M	26.99M	28.85M	29.47M	23.25M	51.82M	75.97M
Short-Term Investments	n/a	2.73M	n/a	n/a	n/a	n/a	18K	15K	15K	15K	15K	17K	8.53M	12.03M	3.52M	16K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	146K	150K	148K	150K	16.17M	16.17M	16.16M	16.16M	16.16M
Other Long-Term Assets	148K	148K	143K	143K	147K	147K	144K	146K	150K	148K	150K	16.16M	16.17M	16.16M	16.16M	16.16M
Receivables	3.57M	2.54M	3.88M	974K	2.59M	2.59M	5.95M	12.02M	37.88M	39.3M	33.76M	25.93M	32.52M	30.04M	30.1M	23.31M
Inventory	3.65M	3.65M	3.8M	3.8M	4.39M	4.39M	4.94M	5.86M	11.01M	12.58M	11.72M	14.27M	14.81M	13.12M	8.76M	9.27M
Other Current Assets	n/a	411K	739K	739K	2.79M	2.79M	9.14M	11.05M	16M	16M	16M	n/a	n/a	n/a	n/a	n/a
Total Current Assets	11.91M	11.91M	15.7M	15.7M	16.14M	16.14M	27.05M	46.52M	85.9M	83.1M	91.27M	72.58M	89.15M	83.11M	98.49M	112.66M
Property-Plant & Equipment	437K	437K	616K	616K	1.18M	1.18M	2.25M	6.57M	7.19M	6.8M	7.81M	8.26M	4.22M	4.67M	4.8M	5.25M
Goodwill & Intangibles	5.55M	5.55M	5.56M	5.56M	5.58M	5.58M	5.59M	5.6M	65.63M	67.14M	68.74M	70.04M	71.64M	82.39M	84.22M	86.05M
Total Long-Term Assets	6.13M	6.13M	6.32M	6.32M	6.91M	6.91M	7.99M	12.32M	72.97M	74.09M	76.7M	94.47M	92.04M	103.22M	105.18M	107.47M
Total Assets	18.04M	18.04M	22.02M	22.02M	23.05M	23.05M	35.04M	58.83M	158.87M	157.19M	167.97M	167.05M	181.19M	186.34M	203.67M	220.12M
Account Payables	7.86M	1.17M	1.91M	1.91M	3.28M	3.28M	3.11M	4.37M	4.23M	4.78M	4.37M	5.71M	11.66M	15.24M	13.31M	6.54M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	37.31M	36.32M	38.08M	35.78M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	115.22M	113.86M	85.51M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	11.31M	9.54M	14.99M	5.1M	3.31M	3.31M	16.38M	43.09M	49.65M	41.78M	39.22M	31.39M	34.37M	28.36M	26.1M	22.68M
Total Current Liabilities	22.22M	22.22M	21.23M	21.23M	19.98M	19.98M	28.19M	48.44M	197.45M	193.53M	166.41M	73.9M	81.47M	81.66M	79.17M	66.63M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	86.4M	83.62M	83.52M	83.16M	82.52M
Other Long-Term Liabilities	500K	500K	540K	540K	540K	540K	2.38M	2.38M	3.37M	3.68M	6.82M	4.81M	4.65M	6.76M	8.79M	14.54M
Total Long-Term Liabilities	503K	503K	730K	730K	995K	995K	3.38M	8.39M	9.82M	9.69M	13.49M	98.39M	90.84M	93.13M	94.92M	100.45M
Total Liabilities	22.73M	22.73M	21.96M	21.96M	20.98M	20.98M	31.57M	56.83M	207.27M	203.22M	179.91M	172.29M	172.31M	174.79M	174.09M	167.08M
Total Debt	356K	356K	558K	558K	1.17M	1.17M	2.28M	6.99M	122.69M	120.83M	93.65M	95.01M	87.81M	88.11M	87.83M	87.55M
Common Stock	35.04M	35.04M	34.78M	34.78M	21.44M	21.44M	4.62M	2.85M	2.83M	1.83M	1.83M	1.51M	1.5M	1.32M	1.31M	1.31M
Retained Earnings	-414.8M	-414.8M	-410.06M	-410.06M	-407.74M	-407.74M	-382.01M	-383.48M	-433.86M	-431.27M	-397.18M	-382.7M	-367.87M	-345.37M	-326.17M	-302.32M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-4.68M	-4.68M	61K	61K	2.07M	2.07M	3.47M	2M	-48.4M	-46.03M	-11.94M	-5.24M	8.88M	11.55M	29.58M	53.04M
Total Investments	n/a	2.73M	n/a	n/a	n/a	n/a	18K	15K	15K	15K	15K	17K	8.53M	12.03M	3.52M	16K